Swedish Orphan Biovitrum (Sobi)

Corporate Headquarters:sobisobi

Tomtebodavägen 23A, Solna
SE-112 76 Stockholm
Sweden

Swedish Orphan Biovitrum (Sobi) is a leading European specialty pharmaceutical company focused on providing and developing specialty pharmaceuticals for patients with rare diseases and significant medical needs. The portfolio comprises about 60 marketed products, as well as projects in late clinical phase. Key therapeutic areas are hematological diseases, autoimmune diseases, hereditary metabolic disorders and therapeutic oncology. Our vision is to be an exciting and leading international rare disease pharmaceutical company.

Recombinant C1-Inhibítor Concentrat - Trade Name: Ruconest/Rhucin

The Dutch biotechnology company, Pharming NV is testing their recombinant C1 inhibitor product (Ruconest/Rhucin) in the US and in Europe. Pharming's product is derived from the milk of female rabbits that have been genetically altered to produce the human C1 inhibitor protein. Clinical trials have shown that Ruconest/Rhucin is a safe and effective treatment for acute HAE attacks. In Europe Ruconest is marketed by Swedish Orphan Biovitrum (Sobi).

Approved by the EMA for treatment of attacks.
The company plans to apply for a US license as well.

 

News

Wed, 2012-05-16

Worldwide Recognition of hae day :-) Unites and Empowers the Global Hereditary Angioedema Community
..continue
Thu, 2012-05-03

CSL Behring Initiates Study of Subcutaneous Administration of C1-esterase Inhibitor in Patients with Hereditary Angioedema
..continue
Wed, 2012-04-11

Dyax Launches Hereditary Angioedema Genetic Counseling Program to Educate Patients and Family Members about Disease and Inheritance
..continue
Mon, 2012-04-09

US HAEA and its Medical Advisory Board Announce Ground-Breaking Scientific Workshop on Angioedema
..continue
Thu, 2012-03-29

ViroPharma Launches Hereditary Angioedema Facebook App to Encourage Education and Diagnosis of Hereditary Angioedema Through Discussion of Family History
..continue
Mon, 2012-03-26

Pharming And Hyupjin Corporation Announce Commercialisation Agreement For Ruconest In Korea
..continue
Newsletter Teaser ( In News Section on Homepage )

Newsletter

Make sure to stay updated. HAEi will keep you informed when you sign up for our newsletter.

Sign up for HAEi Newsletter and register at the same time.

Join our Facebook group - and follow HAEi on Twitter

Facebook logo SFacebook logo STwitter logo STwitter logo S

  

Events

Fri, 2012-05-18 08:00 - Sun, 2012-05-20 12:00

2012 HAE Global Conference

Venue:Scandic Hotel Sydhavnen, Copenhagen, Denmark
Language:English

HAE GLOBAL CONFERENCEHAE GLOBAL CONFERENCE

HAEi is delighted to invite patients, care givers, health care professionals and industry representatives to this biannual first true global conference, where this year's theme is "Advocacy and Access".

We have prepared some VERY ATTRACTIVE conference packages for all delegates.

We expect participation from all over the world.

Read more on the 2012 HAE Global Conference website

 

 ..continue
Wed, 2012-05-16 00:01 - 23:59

2012 HAE Awareness Day

Venue: All over the World!
Language: All languages

HAEDAYHAEDAYPlease have a look at www.haeday.org for more information about this first ever dedicated awareness day for hereditary angioedema (HAE). Find inspiration for national/regional events as well as an overview of planned activities on the hae day website.

 ..continue
Fri, 2012-03-02 08:00 - Tue, 2012-03-06 17:00

AAAAI 2012 Annual Meeting

Venue: Orange County Convention Center, Orlando, Florida, USA
Language: English

The AAAI Annual Meeting is the world's premier gathering of allergy and immunology experts. Attendees include clinicians, academicians, allied health professionals and others interested in allergic and immunologic disease.

The 2012 meeting will take place from March 2 - 6, in Orlando, Florida. We look forward to seeing you in Orlando. Read more about the conference here

 ..continue

Homepage Teaser 6, 2nd row right

HAE Global Community

Be part of the HAEi Community

HAEi is here to help you. Therefore we have created the HAEi Community that gives you all the bells and whistles you know from other social media (such as Facebook) and even a very sophisticated Forum, where you can discuss with fellow HAE patients and care givers. The only difference is - that here your information stays safe - and will only be shared with other HAE patients and care givers. If you are a HAE patient or directly related to a HAE patient we urge you to register today - and become an important member of our community

Help yourself and stay updated by registering already today - then you will be the first to know.....

Go to Registration page

Do you have Questions?
You can find answers on our FAQ-Page or
send us an e-mail to: info@haei.org
 or go to the contact form page

Experiencing browser problems?

Our website is working properly on most web browsers. However, we know that the site will not perform correctly on Microsoft Internet Explorer version 6 and earlier! So if you are using Internet Explorer from Microsoft please ensure that you have version 7 or higher!

HAEi is a proud supporter of EURORDIS/NORD Rare Disease Day

RDD logoRDD logo

HAEDAYHAEDAYLook out for the first ever HAE Awareness Day on 16 May 2012


www.haeday.org